Mike Loftus Now Chairman of American Diabetes Association, New Jersey


Sheri Farsakh
Tel (657) 900-5232

Tustin, Calif. - February 2, 2015

Integrium Clinical Research commends Executive Director of Business Development, Mike Loftus, in recognition of his new role as American Diabetes Association Community Leadership Board Chairman. Mike dedicates himself to actively lead the fight against diabetes by bringing new business to the world of clinical research. A driven passion built upon his past four years of leadership in the biopharmaceutical industry, has presented him with a dynamic networking sphere comprised of specialty and development-stage biopharmaceutical companies. His cordial approach to business brings forward a prolific exchange of ideas Integrium is confident will serve the northern New Jersey community under the wings of the American Diabetes Association (ADA).

Following the first ADA Community Leadership Board Meeting of 2015, preparations to host the upcoming Father of the Year event are now underway. Ready to share, act, learn, and give commitment as Board Chair, Mike seeks to connect with fellow board members on an individual basis. As a leader, he has positioned the team in the right direction, as indicated by ADA Executive Director, Denise M. Andersen.

"The American Diabetes Association's Northern New Jersey Community Leadership Board and I are thrilled that Mike has taken on the role as Chairman. Mike is a skilled relationship builder who has brought truly valuable partnerships to the Association. His strong business acumen will position the NNJ Market for tremendous growth as the American Diabetes Association observes our 75th Anniversary, Celebrating Discovery, Innovation and Progress. The Association will honor 75 years of progress in diabetes treatment, management and quality of life, and our role in these advancements. With Mike as our volunteer leader, we will aim to create greater awareness of the seriousness of diabetes by acknowledging decades of diabetes discovery and treatment as well as focusing on the progress we've made and the work that still needs to be accomplished."

Father of the Year Awards - confirmed Fathers for 2015:

John Pennett, Partner, Eisner Amper
Nauman Shah, Vice President, Sales and Marketing, Metabolics at Janssen,
Pharmaceutical Companies of Johnson and Johnson
Garrick Stoldt, Chief Financial Officer, St. Peter's Healthcare System

The American Diabetes Association strongly embraces their mission to provide diabetes research, information and advocacy as a leading nonprofit charity since 1940. In pursuit of expanding the field of diabetes research, the association has managed a research foundation in which provides direct funding to more than 160 research institutions today. The ADA movement seeks to improve the conditions for people with diabetes and pre-diabetes while also giving voice to those deprived of their rights because of the consequences of diabetes. By drawing experience and perspective from staff, volunteers, and partner organizations, the ADA continues to help our communities strive for a better future against diabetes.

For more information, please contact Mike Loftus
(908) 295-4578

About Integrium, LLC

Integrium Clinical Research specializes in the strategy, study design, and execution of Phase I-IV clinical trials, with an expertise in Proof of Concept trials. The firm has strong clinical trial experience in a range of therapeutic indications including cardiovascular, metabolic, renal, inflammatory, dermatology, regenerative, orphan, and wound healing drug development. It has a strong reputation for delivering high-quality management of global clinical development programs and service to its clients. Combining the Integrium Clinical Excellence (ICE) study start-up and management methodology, and therapeutic expertise leads sponsors to more confident, better-informed drug and device development decisions. For more information please visit www.integrium.com.